Value Investing through Gurus model portfolios. | Equity School | - D - Dishman Pharmaceuticals and Chemicals Ltd

You are here: Home

Balance Sheet of Dishman Pharmaceuticals and Chemicals Ltd

Balance Sheet of Dishman Pharmaceuticals and Chemicals Ltd

	Mar2008	Mar2007	Mar2006	Mar2005	Mar2004
SOURCES OF FUNDS:
Share Capital	15.94	14.44	13.73	13.73	10.30
Reserves & Surplus	437.85	254.79	157.81	128.61	53.62
Total Shareholders Funds	453.79	269.23	171.54	142.34	63.92
Secured Loans	206.19	126.72	45.95	98.47	94.81
Unsecured Loans	56.32	171.73	247.83	5.70	15.92
Total Debt	262.51	298.45	293.78	104.17	110.73
Total Liabilities	716.30	567.68	465.32	246.51	174.65
APPLICATION OF FUNDS:
Gross Block	326.33	259.78	191.76	150.88	125.10
Less: Accum. Depreciation	70.70	54.70	40.78	31.38	23.75
Net Block	255.63	205.08	150.98	119.50	101.35
Capital Work in Progress	110.62	49.10	37.31	12.85	6.14
Investments	132.51	131.29	12.04	5.61	2.62
Inventories	120.63	98.65	84.53	64.31	48.47
Sundry Debtors	111.49	120.72	77.44	63.88	40.65
Cash and Bank Balance	4.49	4.95	124.03	2.17	1.84
Loans and Advances	89.34	89.21	42.28	25.35	17.74
Current Liabilities	78.26	112.16	49.74	36.92	38.57
Provisions	30.79	19.93	14.63	10.97	8.59
Net Current Assets	216.90	181.44	263.91	107.82	61.54
Miscellaneous Expenses not w/o	0.64	0.77	1.08	0.73	3.00
Total Assets	716.30	567.68	465.32	246.51	174.65
Contingent Liabilities	401.52	299.07	62.99	56.40	54.60

High Dividend, High Value, Fast Growth - Stock Research Based on Strategies of the Pros, including Warren Buffett, Peter Lynch and Ben Graham